REST and neoplasm: For example, TRIM28 has been identified as a binding partner of REST [45], which is known to have germline or somatic mutations in approximately 2% of Wilms tumours [23]; however, reported tumours with REST mutations had more varied histology and older ages at diagnosis than our group of TRIM28-mutant tumours.